DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Akums Drugs and Pharmaceuticals Limited — Outcome of Board Meeting

NSE 1 hr ago·2 Nov 2026, 11:44 am

Akums Drugs AND Pharma L

Akums Drugs and Pharmaceuticals Limited has informed the stock exchange regarding its financial results for the period ending September 30, 2026. This disclosure is a routine regulatory requirement that allows the company to share its performance data with the market. The board has reviewed the accounts and submitted the necessary filings, which investors can access on the exchange's official website.

For investors, this update provides a snapshot of the company's operational health during the third quarter of the financial year. It offers a chance to assess the firm's revenue generation and profitability trends against previous periods. Monitoring these figures helps in understanding the company's current market position and growth trajectory.

Investors should look for specific details on revenue growth, profit margins, and any commentary from the management regarding future outlook. Keeping an eye on the company's guidance and sector performance will be key to gauging the stock's potential direction following this announcement.